Sramana Mitra: Is there any other category that we should discuss in a bit more detail?
Brandon Colby: The third use case deals with bioinformatics companies. Even though there is test data that is being generated by 23andme and Ancestry, the format of the data is unique per company. It gets very complex in terms of dealing with the bioinformatics of making one company’s test data compatible with another. That is something that we specialize in.
>>>Sramana Mitra: What kind of price points are we talking about?
Brandon Colby: The nutrition DNA analysis apps are priced around $20 to $60. There are some that are priced a bit more than that and others a bit less. These reports don’t just provide one little bit of information.
These are 10 to 30 pages long. They provide a ton of information for the individual to understand their DNA. They look at several genes. It’s a complex type of analysis that is packaged and delivered in a very simple and straightforward way.
>>>Sramana Mitra: So you’re a B2C service?
Brandon Colby: We have a B2C arm. Our website is a marketplace for consumers. We also work in two different ways in terms of B2B. One is with app developers from bioinformatics companies.
These are companies that understand genetics analysis. They create some type of useful interpretation of DNA data. They provide their analysis services and reports through our marketplace.
>>>This is a fascinating conversation on personalized Genomics Analysis applications.
Sramana Mitra: Let’s start by introducing our audience to you as well as to the company.
>>>Sramana Mitra: I’d like to do some use cases across those two different bodies of problems and solutions. Help me out with a few use cases.
John Steele: I’ll start with revenue integrity. We take and analyze our client’s data. We identify where there are gaps in that data whether supplemental documentation needs to be received to support it or it’s missing.
>>>John discusses analytics use cases in healthcare.
Sramana Mitra: Let’s start by introducing our audience to yourself as well as to Pareto.
>>>Sramana Mitra: Is there any geographical bias in who’s adopting?
Michele Perry: We’re in 49 of the 50 states. Other than South Dakota, we have clients in every state. We see it everywhere from the lone dermatologist to complete health systems.
Sramana Mitra: If you’re going that broad from a science point of view, how do you sell? Do you sell direct? Do you sell online? How is your channel setup?
>>>Sramana Mitra: We are part of the Stanford healthcare system. In there, we get all the things that you’re talking about. I’m just wondering if that’s through their Epic system. You seem to indicate that this is not part of the baseline systems that they have.
Michele Perry: I don’t know enough about Stanford and what they’ve implemented there. I just know, in general, what we see out there. We have lots of Epic sites that have added these capabilities.
>>>